Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -14.31%45.4M | ---- | 108.72%52.98M | ---- | -70.38%25.39M | ---- | -17.26%85.7M | ---- | 2,038.38%103.59M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -17.11%-22.05M | ---- | 30.04%-18.82M | ---- | -116.14%-26.91M | ---- | -51.14%-12.45M | ---- | 0.18%-8.24M |
| Dividend (income)- adjustment | ---- | 56.49%-456K | ---- | -249.33%-1.05M | ---- | 72.38%-300K | ---- | -213.87%-1.09M | ---- | 23.28%-346K |
| Investment loss (gain) | ---- | ---- | ---- | ---3.42M | ---- | ---- | ---- | ---12.99M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -30.71%3.02M | ---- | -70.54%4.35M | ---- | 33.48%14.77M | ---- | 163.46%11.07M | ---- | -80.70%4.2M |
| Impairment and provisions: | ---- | -13.41%15.96M | ---- | 1,007.19%18.43M | ---- | -128.85%-2.03M | ---- | 1,194.85%7.04M | ---- | -98.59%544K |
| -Impairmen of inventory (reversal) | ---- | -95.56%26K | ---- | 29,200.00%586K | ---- | --2K | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -91.83%204K | ---- | 945.19%2.5M | ---- | -73.99%239K | ---- | 431.21%919K | ---- | -96.82%173K |
| -Other impairments and provisions | ---- | 2.49%15.73M | ---- | 775.32%15.35M | ---- | -137.11%-2.27M | ---- | 1,550.94%6.13M | ---- | --371K |
| Revaluation surplus: | ---- | -63.46%-43.27M | ---- | -278.26%-26.47M | ---- | 146.02%14.85M | ---- | -1,429.46%-32.27M | ---- | 107.52%2.43M |
| -Fair value of investment properties (increase) | ---- | -18.56%-23.81M | ---- | -47.90%-20.09M | ---- | 10.59%-13.58M | ---- | -190.05%-15.19M | ---- | 176.71%16.87M |
| -Derivative financial instruments fair value (increase) | ---- | 296.41%711K | ---- | -51.46%-362K | ---- | -29.89%-239K | ---- | -167.90%-184K | ---- | --271K |
| -Other fair value changes | ---- | -234.83%-20.17M | ---- | -121.01%-6.02M | ---- | 269.73%28.67M | ---- | -14.81%-16.89M | ---- | -42.87%-14.71M |
| Asset sale loss (gain): | ---- | 88.15%-57K | ---- | 94.90%-481K | ---- | -409.83%-9.44M | ---- | 95.96%-1.85M | ---- | -3,090.53%-45.79M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | -1,710.20%-6.21M | ---- | 99.25%-343K | ---- | ---45.79M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---57K | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | 85.09%-481K | ---- | -113.93%-3.23M | ---- | ---1.51M | ---- | ---- |
| Depreciation and amortization: | ---- | -38.20%1.63M | ---- | -31.49%2.64M | ---- | 7.72%3.85M | ---- | -54.79%3.58M | ---- | 27.73%7.91M |
| -Amortization of intangible assets | ---- | ---- | ---- | -25.86%43K | ---- | 93.33%58K | ---- | -88.28%30K | ---- | -4.12%256K |
| Financial expense | ---- | -9.77%10.29M | ---- | -0.34%11.41M | ---- | 36.52%11.45M | ---- | -38.72%8.39M | ---- | -16.54%13.68M |
| Exchange Loss (gain) | ---- | -288.66%-3.39M | ---- | -119.97%-873K | ---- | 16.53%4.37M | ---- | 288.30%3.75M | ---- | ---1.99M |
| Special items | ---- | ---- | ---- | 18,742.86%1.31M | ---- | -101.48%-7K | ---- | -88.10%472K | ---- | --3.97M |
| Operating profit before the change of operating capital | ---- | -82.30%7.08M | ---- | 11.14%40.01M | ---- | -39.35%36M | ---- | -25.77%59.36M | ---- | 112.28%79.96M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -10.78%1.32M | ---- | -65.35%1.48M | ---- | -16.95%4.26M | ---- | 169.04%5.13M | ---- | -277.89%-7.43M |
| Developing property (increase)decrease | ---- | -1,112.51%-27.43M | ---- | 62.97%-2.26M | ---- | 74.05%-6.11M | ---- | -161.83%-23.54M | ---- | -1.16%-8.99M |
| Accounts receivable (increase)decrease | ---- | 220.30%199.5M | ---- | -792.01%-165.83M | ---- | 125.59%23.96M | ---- | -940.94%-93.65M | ---- | 306.84%11.14M |
| Accounts payable increase (decrease) | ---- | 312,060.00%15.61M | ---- | 100.10%5K | ---- | 56.39%-5.12M | ---- | -277.02%-11.73M | ---- | -32.57%6.63M |
| Cash from business operations | ---- | 254.87%196.08M | ---- | -338.92%-126.61M | ---- | 182.25%52.99M | ---- | -179.25%-64.43M | ---- | 117.41%81.31M |
| Other taxs | ---- | -2.03%-10.08M | ---- | -0.39%-9.88M | ---- | 47.75%-9.84M | ---- | -79.37%-18.84M | ---- | 23.44%-10.5M |
| Special items of business | -112.23%-13.36M | ---- | 231.23%109.29M | ---- | -222.43%-83.28M | ---- | 205.86%68.02M | ---- | -119.02%-64.25M | ---- |
| Net cash from operations | -112.23%-13.36M | 236.27%186M | 231.23%109.29M | -416.31%-136.49M | -222.43%-83.28M | 151.82%43.15M | 205.86%68.02M | -217.60%-83.27M | -119.02%-64.25M | 178.66%70.81M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 27.77%12.97M | -56.41%12.56M | -31.35%10.15M | 356.92%28.81M | 706.05%14.78M | -49.17%6.31M | 1,367.20%1.83M | 30.76%12.41M | -96.44%125K | 136.41%9.49M |
| Dividend received - investment | ---- | -56.49%456K | -53.92%458K | 249.33%1.05M | 224.84%994K | -72.38%300K | -71.53%306K | -96.21%1.09M | -96.24%1.08M | 6,251.88%28.65M |
| Loan receivable (increase) decrease | 81.56%-39.09M | -966.66%-259.67M | -174.11%-212M | 112.12%29.96M | 76.31%-77.34M | ---247.12M | -124.21%-326.44M | --0 | -64.31%-145.6M | --0 |
| Decrease in deposits (increase) | ---- | 138.03%4.6M | ---- | -3,513.28%-12.08M | -263.81%-1.91M | 197.52%354K | ---525K | ---363K | ---- | ---- |
| Sale of fixed assets | ---- | -97.69%173K | ---- | 124,850.00%7.5M | ---- | --6K | --6K | ---- | ---- | ---- |
| Purchase of fixed assets | -1,218.18%-580K | 84.04%-132K | 87.21%-44K | 18.28%-827K | 42.28%-344K | 84.39%-1.01M | 8.31%-596K | -1,675.62%-6.48M | -261.11%-650K | -170.37%-365K |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | -14.29%-40K | ---- | 32.69%-35K | ---- | -1,200.00%-52K |
| Sale of subsidiaries | --4.04M | -89.22%433K | ---- | --4.02M | ---- | ---- | ---- | ---- | ---- | --14M |
| Recovery of cash from investments | 12.88%596K | -89.74%3.65M | -97.22%528K | 217.75%35.56M | 428.87%19.02M | -93.11%11.19M | -98.32%3.6M | --162.41M | --214.4M | ---- |
| Cash on investment | ---- | 59.95%-16.04M | -102.66%-381K | -384.80%-40.05M | 97.77%-188K | -7.75%-8.26M | -245.27%-8.41M | 39.84%-7.67M | 152.03%5.79M | 85.54%-12.75M |
| Other items in the investment business | ---- | ---- | ---- | -100.21%-217K | -99.98%20K | 48,730.66%103.52M | 100.26%87.58M | -99.69%212K | -57.11%43.74M | 125.14%69.17M |
| Net cash from investment operations | 89.04%-22.07M | -572.80%-253.98M | -347.63%-201.3M | 139.86%53.72M | 81.47%-44.97M | -183.41%-134.76M | -304.11%-242.65M | 49.41%161.56M | 248.25%118.88M | 130.03%108.14M |
| Net cash before financing | 61.50%-35.43M | 17.87%-67.98M | 28.26%-92.01M | 9.64%-82.77M | 26.56%-128.25M | -217.00%-91.61M | -419.65%-174.64M | -56.25%78.29M | 1,037.71%54.63M | 153.47%178.94M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 286.60%48.34M | 33.91%126.51M | --12.5M | -33.10%94.48M | ---- | 290.02%141.22M | --95.88M | 249.19%36.21M | ---- | -95.70%10.37M |
| Refund | -55.63%-19.34M | -202.71%-105.67M | -65.37%-12.43M | 29.71%-34.91M | -13.99%-7.51M | -111.02%-49.66M | 60.60%-6.59M | 86.90%-23.54M | 80.57%-16.73M | -21.14%-179.7M |
| Interest paid - financing | 22.34%-4.77M | 8.63%-10.26M | -7.79%-6.14M | -1.06%-11.23M | -20.22%-5.7M | -34.26%-11.11M | -10.96%-4.74M | 37.08%-8.28M | 35.42%-4.27M | 17.33%-13.16M |
| Dividends paid - financing | ---- | 75.00%-16.38M | ---- | ---65.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---8.86M | ---- | ---- | 99.10%-335K | 100.00%-1K | 9.00%-37.02M | ---35.25M | ---40.68M | ---- | ---- |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 212.61%82.68M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -140.10%-2M |
| Net cash from financing operations | 337.00%15.09M | 66.19%-6.39M | 54.45%-6.37M | -145.07%-18.9M | -128.76%-13.98M | 209.71%41.93M | 320.45%48.6M | 64.90%-38.22M | -218.83%-22.05M | -133.22%-108.88M |
| Effect of rate | 126.30%339K | 33.71%-1.99M | 63.37%-1.29M | 74.78%-3.01M | 54.32%-3.52M | -1,155.68%-11.93M | -489.89%-7.7M | -113.25%-950K | 17.81%-1.31M | 260.04%7.17M |
| Net Cash | 79.33%-20.34M | 26.85%-74.37M | 30.83%-98.38M | -104.67%-101.67M | -12.85%-142.23M | -223.96%-49.68M | -486.77%-126.03M | -42.81%40.07M | 1,642.17%32.59M | 1,114.71%70.07M |
| Begining period cash | -71.83%29.94M | -49.61%106.31M | -49.61%106.31M | -22.60%210.99M | -22.60%210.99M | 16.76%272.59M | 16.76%272.59M | 49.44%233.47M | 49.44%233.47M | -3.05%156.23M |
| Cash at the end | 49.74%9.95M | -71.83%29.94M | -89.82%6.64M | -49.61%106.31M | -53.01%65.24M | -22.60%210.99M | -47.55%138.86M | 16.76%272.59M | 73.57%264.75M | 49.44%233.47M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.